Skip to content

Clinical trials

Terminated Urinary Bladder Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Terminated Country / region: United States Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20031
20041
20056
20062
20072
20083
20095
20107
201110
20127
20135
20146
20159
20169
201714
20186
20197
20208
202110
20224
20235
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
M.D. Anderson Cancer Center5
Memorial Sloan Kettering Cancer Center5
Pfizer4
SWOG Cancer Research Network4
Spectrum Pharmaceuticals, Inc4
University of Michigan Rogel Cancer Center4
Bristol-Myers Squibb3
Matthew Galsky3
University of Southern California3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms136
Carcinoma, Transitional Cell26
Carcinoma, Non-Small-Cell Lung23
Neoplasms17
Melanoma16
Ovarian Neoplasms16
Colorectal Neoplasms14
Breast Neoplasms13
Non-Muscle Invasive Bladder Neoplasms13
Stomach Neoplasms13

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.